著者検索結果

1

Nivolumab in renal cell carcinoma: latest evidence and clinical potential 著者: Camille Mazza, Bernard Escudier, Laurence Albigès

出版事項 2016

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
2

Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma 著者: Elie Rassy, Ronan Flippot, Laurence Albigès

出版事項 2020

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
3

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer 著者: Karim Fizazi, Laurence Albigès, Yohann Loriot, Christophe Massard

出版事項 2015

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
4

Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma 著者: Hassan Izzedine, Lisa Derosa, Gwénaël Le Teuff, Laurence Albigès, Bernard Escudier

出版事項 2015

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
5

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases 著者: Laurence Albigès, Fabrice André, Corinne Balleyguier, Gonzalo Gomez-Abuin, Agnès Chompret, Suzette Delaloge

出版事項 2005

全文の入手全文の入手
Carta

お気に入りに追加

保存先:
6

TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma 著者: Laurence Albigès, Philippe Barthélémy, Marine Gross‐Goupil, Sylvie Négrier, Michael N. Needle, Bernard Escudier

出版事項 2020

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
7

Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma 著者: Laurence Albigès, Foucauld Chamming’s, Brigitte Duclos, M. Stern, Robert J. Motzer, Alain Ravaud, P. Camus

出版事項 2012

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
8

Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography 著者: Nathalie Lassau, Serge Koscielny, Laurence Albigès, L. Chami, Baya Benatsou, Mohamed Chébil, Alain Roche, Bernard Escudier

出版事項 2010

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
9

Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma 著者: Christophe Maritaz, David Combarel, Cécile Dalban, Louis Blondel, Sophie Broutin, Aurélien Marabelle, Laurence Albigès, Angélo Paci

出版事項 2025

全文の入手
Artigo

お気に入りに追加

保存先:
10

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events 著者: Viktor Grünwald, Martin H. Voss, Brian I. Rini, Thomas Powles, Laurence Albigès, Rachel H. Giles, Eric Jonasch

出版事項 2020

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
11

Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients 著者: Luc Cabel, Elika Loir, Gwénaëlle Gravis, Pernelle Lavaud, Christophe Massard, Laurence Albigès, Giulia Baciarello, Yohann Loriot, Karim Fizazi

出版事項 2017

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
12

Radiologic Heterogeneity in Responses to Anti–PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma 著者: Guillermo de Velasco, Katherine M. Krajewski, Laurence Albigès, Mark M. Awad, Joaquim Bellmunt, F. Stephen Hodi, Toni K. Choueiri

出版事項 2015

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
13

ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma 著者: Thomas Powles, Laurence Albigès, Axel Bex, Viktor Grünwald, Camillo Porta, Giuseppe Procopio, Manuela Schmidinger, Cristina Suárez, Guillermo de Velasco

出版事項 2021

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
14

Who dies from prostate cancer? 著者: Anna Patrikidou, Yohann Loriot, J-C Eymard, Laurence Albigès, Christophe Massard, E. Ileana, Mario Di Palma, Bernard Escudier, Karim Fizazi

出版事項 2014

全文の入手
Artigo

お気に入りに追加

保存先:
15

Renal cell carcinoma 著者: James J. Hsieh, Mark P. Purdue, Sabina Signoretti, Charles Swanton, Laurence Albigès, Manuela Schmidinger, Daniel Y.C. Heng, James Larkin, Vincenzo Ficarra

出版事項 2017

全文の入手
Revisão

お気に入りに追加

保存先:
16

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100) 著者: Yohann Loriot, Diletta Bianchini, E. Ileana, Shahneen Sandhu, Anna Patrikidou, Carmel Pezaro, Laurence Albigès, Gerhardt Attard, Karim Fizazi, Johann S. de Bono, Christophe Massard

出版事項 2013

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
17

Thermal Ablation Combined with Immune Checkpoint Blockers: A 10-Year Monocentric Experience 著者: Baptiste Bonnet, Louis Tournier, Frédèric Deschamps, Steven Yevich, Aurélien Marabelle, Caroline Robert, Laurence Albigès, Benjamin Besse, V Bonnet, Thierry de Baère, Lambros Tselikas

出版事項 2024

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
18

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma 著者: Anthony Saroufim, Yosra Messai, Meriem Hasmim, Nathalie Rioux, Roberto Iacovelli, G. Verhoest, Karim Bensalah, J-J Patard, Laurence Albigès, Bruno Azzarone, Bernard Escudier, Salem Chouaı̈b

出版事項 2014

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
19

Chk1 as a new therapeutic target in triple-negative breast cancer 著者: Laurence Albigès, Aïcha Goubar, Véronique Scott, Cécile Vicier, Céline Lefèbvre, Samar Alsafadi, Frédéric Commo, Mahasti Saghatchian, Vladimir Lazar, Philippe Dessen, Suzette Delaloge, Fabrice André, Virginie Quidville

出版事項 2014

全文の入手
Artigo

お気に入りに追加

保存先:
20

Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors 著者: Sarah C. Markt, Carlos Lago‐Hernandez, Rowan Miller, Brandon A. Mahal, Brandon Bernard, Laurence Albigès, Lindsay A. Frazier, Clair J. Beard, Alexi A. Wright, Christopher J. Sweeney

出版事項 2016

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:

検索結果 - Laurence Albigès

Nivolumab in renal cell carcinoma: latest evidence and clinical potential 著者: Camille Mazza, Bernard Escudier, Laurence Albigès

Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma 著者: Elie Rassy, Ronan Flippot, Laurence Albigès

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer 著者: Karim Fizazi, Laurence Albigès, Yohann Loriot, Christophe Massard

Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma 著者: Hassan Izzedine, Lisa Derosa, Gwénaël Le Teuff, Laurence Albigès, Bernard Escudier

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases 著者: Laurence Albigès, Fabrice André, Corinne Balleyguier, Gonzalo Gomez-Abuin, Agnès Chompret, Suzette Delaloge

TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma 著者: Laurence Albigès, Philippe Barthélémy, Marine Gross‐Goupil, Sylvie Négrier, Michael N. Needle, Bernard Escudier

Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma 著者: Laurence Albigès, Foucauld Chamming’s, Brigitte Duclos, M. Stern, Robert J. Motzer, Alain Ravaud, P. Camus

Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography 著者: Nathalie Lassau, Serge Koscielny, Laurence Albigès, L. Chami, Baya Benatsou, Mohamed Chébil, Alain Roche, Bernard Escudier

Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma 著者: Christophe Maritaz, David Combarel, Cécile Dalban, Louis Blondel, Sophie Broutin, Aurélien Marabelle, Laurence Albigès, Angélo Paci

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events 著者: Viktor Grünwald, Martin H. Voss, Brian I. Rini, Thomas Powles, Laurence Albigès, Rachel H. Giles, Eric Jonasch

Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients 著者: Luc Cabel, Elika Loir, Gwénaëlle Gravis, Pernelle Lavaud, Christophe Massard, Laurence Albigès, Giulia Baciarello, Yohann Loriot, Karim Fizazi

Radiologic Heterogeneity in Responses to Anti–PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma 著者: Guillermo de Velasco, Katherine M. Krajewski, Laurence Albigès, Mark M. Awad, Joaquim Bellmunt, F. Stephen Hodi, Toni K. Choueiri

ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma 著者: Thomas Powles, Laurence Albigès, Axel Bex, Viktor Grünwald, Camillo Porta, Giuseppe Procopio, Manuela Schmidinger, Cristina Suárez, Guillermo de Velasco

Who dies from prostate cancer? 著者: Anna Patrikidou, Yohann Loriot, J-C Eymard, Laurence Albigès, Christophe Massard, E. Ileana, Mario Di Palma, Bernard Escudier, Karim Fizazi

Renal cell carcinoma 著者: James J. Hsieh, Mark P. Purdue, Sabina Signoretti, Charles Swanton, Laurence Albigès, Manuela Schmidinger, Daniel Y.C. Heng, James Larkin, Vincenzo Ficarra

Thermal Ablation Combined with Immune Checkpoint Blockers: A 10-Year Monocentric Experience 著者: Baptiste Bonnet, Louis Tournier, Frédèric Deschamps, Steven Yevich, Aurélien Marabelle, Caroline Robert, Laurence Albigès, Benjamin Besse, V Bonnet, Thierry de Baère, Lambros Tselikas

検索ツール:

関連主題